companydata.dkChosa ApS: Financial statements 2024
CVR: 43134477
Chosa ApS (CVR 43134477) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,130,610 and a net result of DKK -3,586,839 compared with DKK -2,069,955 the year before. Equity amounted to DKK 7,484,752. The solvency ratio was 66.9%. The company had 1 employee in the financial year.
- Gross Profit
- -1,130,610 kr.
- Profit/Loss
- -3,586,839 kr.
- Equity
- 7,484,752 kr.
- Total Assets
- 11,189,475 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -1.1 mio. | -3.6 mio. | 7.5 mio. | 1 |
| 2023 | - | -1.5 mio. | -2.1 mio. | 9 mio. | 0 |
How creditworthy is Chosa ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Chosa ApS has published its annual report for 2023. Gross profit came to DKK -1,542,553, and the net result was DKK -2,069,955.
About Chosa ApS
Chosa ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Claus Frisenberg Pedersen and Peter Buhl. The company is owned by Chosa Oncology AB. In 2025, the company reported a gross profit of DKK -2,136,143 and a net result of DKK -2,632,024 compared with DKK -3,586,839 the year before. Equity amounted to DKK 5,175,030.